红日药业：第三季度归母净利润213.29万元，同比下降89.40%

Core Insights - Hongri Pharmaceutical reported a revenue of 1.354 billion yuan for Q3 2025, representing a year-on-year decline of 6.32% [1] - The net profit attributable to shareholders was 2.1329 million yuan, down 89.40% year-on-year [1] - Basic earnings per share stood at 0.001 yuan [1] Financial Performance - For the first three quarters, the company achieved a revenue of 4.149 billion yuan, a decrease of 6.59% compared to the previous year [1] - The net profit attributable to shareholders for the same period was 80.7629 million yuan, reflecting a year-on-year decline of 52.03% [1] - Basic earnings per share for the first three quarters were 0.03 yuan [1]